Back to results

Massachusetts Institute of Technology

Tactical planning optimization for campaign scheduling of active pharmaceutical ingredient production based on monoclonal antibodies

Abstract

dc:description.abstract

Monoclonal Antibodies (mAb's) are the fastest growing segment in the biopharmaceutical industry. They are used today as therapeutics and diagnostics for several medical applications, including various types of cancer, rheumatoid arthritis, psoriasis, severe asthma macular degeneration, multiple sclerosis and more. In recent years, industry trends and market pressure have driven pharmaceutical companies to focus efforts on increasing operational efficiency in order to reduce the financial burden associated with drug manufacturing. Consequentially, Novartis Pharma Technical Operations' is currently engaging in efforts to obtain Class "A" Manufacturing Resource Planning (MRP II). This project was chosen to analyze and address the current Integrated Business Planning (IBP) technically and financially by analyzing critical processes, their bottlenecks, and prioritizing improvement opportunities. We focus on tactical planning at the Multiproduct Process Unit at BioPharm Ops. This paper describe the development of a Tactical Planning optimization tool, which implements SuperPro Designerc and ScheduleProC (Intelligen Inc., NJ, USA) for campaign scheduling of active pharmaceutical ingredient production based on mammalian monoclonal antibodies (mAb's). Results have shown great potential benefits for Novartis, including but not limited to: Creating and modifying campaign schedules in hours (not days); increased operational efficiency; Max Run Rate Optimization, cycle time reduction and significant production cost savings; analytic tool to support long-term strategic decisions with the flexibility to address real-time adversity and automated conflict resolving.

Degree

thesis:*
Department dc:contributor.department
Leaders for Global Operations Program at MIT
Grantor dc:publisher
Massachusetts Institute of Technology
Year dc:date.issued
2014

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Assia, Shai
Advisor dc:contributor.advisor
  • Charles L. Cooney and Roy Welsch.

Subjects

dc:subject × 3

Rights

dc:rights
Statement dc:rights
  • M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission.
Language dc:language.iso
eng

Identifiers

dc:identifier.*
Handle dc:identifier.uri
http://hdl.handle.net/1721.1/90765
OAI identifier oai:identifier
oai:dspace.mit.edu:1721.1/90765

Chain of custody

source
Harvested from
MIT
Base URL
dspace.mit.edu/oai/request
Last updated
2026-07-22
Source record
OAI-PMH GetRecord
citation

Assia, Shai. Tactical planning optimization for campaign scheduling of active pharmaceutical ingredient production based on monoclonal antibodies. Massachusetts Institute of Technology, 2014. http://hdl.handle.net/1721.1/90765